LOTS Blog Business Annual

Scale multi‑site publishing with high traffic, large AI credits, and live support. Designed for agencies, media teams, and brands with several blogs.

7 days free trial

Available on:

🎁 Free Trial

Yearly

$499/yr
7 days free trial • Cancel anytime
Secure checkoutInstant accessCancel anytime

About This Product

For content studios, agencies, and brands that run multiple sites, publish at scale, and need higher performance, AI capacity, and real-time support.

Business is the plan for teams that deliver content as a core service. It’s optimized for multi-site management, heavier traffic, and production workflows that require fast help and robust integrations.


What You Get

  • Up to 10 professional blogs
  • 300,000 monthly visits
  • 1,000 AI credits monthly
  • Live chat support
  • Unlimited posts & pages - Create as much content as you need
  • Custom domain support - Use your own branded domain
  • Custom themes - Personalize your blog's appearance
  • Full SEO & GEO compatible - Optimize for search engines and global reach
  • Analytics dashboard - Track your blog's performance
  • Comments module - Engage with your audience

How This Fits Your Workflow

Business supports agency-style workflows: multiple editors, client sites, and production calendars. Generous AI credits speed drafting across projects, while live chat and priority channels keep support turnaround fast. Higher visit limits let you run traffic-driven strategies without frequent surprises.


Who Chooses Business?

  • Content agencies and social-first studios
  • D2C brands and media startups with several properties
  • In-house marketing teams managing agency-like output
  • Publishers who need multi-site control and immediate support

If your operation requires dependable performance, team features, and hands-on support, Business is the plan built for scale.

Power your multi-site publishing operation.

Ready to get started with LOTS Blog Business Annual?

Start your 7 days free trial today. Cancel anytime during trial.